Diabetomics Inc. Changes Name to Modality Dx Amid New Innovation and Expansion of Molecular Signature Diagnosis Products

PORTLAND, Ore.--(BUSINESS WIRE)--Diabetomics has been rebranded Modality Dx. Founded by Dr. Srinivasa Nagalla, Modality Dx is an innovator in rapid test technologies for risk assessment and diagnosis in maternal health, diabetes and autoimmune disease. “Throughout my career, I’ve seen firsthand the great need for more preventive healthcare solutions,” said Dr. Nagalla. “Too often doctors see patients after disease has already taken hold. My goal is to develop diagnostic tools that can assist in